On the positive side, continued growth in sales of key drugs like Darzalex, along with newer products such as Erleada and ...

Now that the JNJ stock has seen a 7% fall, does the current price point make it attractive? Going by what you pay per dollar ...

Johnson & Johnson (JNJ) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some ...

Johnson & Johnson (JNJ) has been one of the most searched ... between trends in earnings estimate revisions and near-term stock price movements. For the current quarter, Johnson & Johnson is ...

Stock Market Making New Highs as Election Nears After a rocky start to October, the stock market is again posting new all-time highs. As of the 10/11/24 close, the S&P 500 was up 21.9% for 2024 ...

If an investor was to purchase shares of JNJ stock at the current price level of $148.97/share, and then sell-to-open that call contract as a "covered call," they are committing to sell the stock ...

Shares of Johnson & Johnson ( JNJ 3.04%) are tumbling on Tuesday. The company's stock lost 6.3% as of 2:25 p.m. ET. The drop ...

JOHNSON & JOHNSON (JNJ) is a large-cap growth stock in the Biotechnology & Drugs industry. The rating using this strategy is 87% based on the firm’s underlying fundamentals and the stock’s ...

Recently, UBS analyst Danielle Antalffy reiterated a Buy rating on Johnson & Johnson stock with a price target of $180. The analyst noted that a federal judge rejected JNJ’s third attempt to use ...